Free National NPI Number Registry

Dr. Matthew Scott Yasmer

Home >Dr. Matthew Scott Yasmer

 

NPI Number Detailed Information

Provider Information:

Name: Dr. Matthew Scott Yasmer
Gender: M
Provider License Number If Given: N005224

NPI Information:

NPI: 1699713511
Entity Type
(Individual or Organization):
1-ind
Enumeration Date: 6/3/2006

Last Update Date: 11/15/2011

Reputation Report:

Provider Business Mailing Address:

Address: 367 HEMPSTEAD AVE
West Hempstead, NY 11552
Phone Number: 5164818099
Fax Number: 5166560660

Provider Business Practice Location Address:

Address: 367 HEMPSTEAD AVE
West Hempstead, NY 11552
Phone Number: 5164818099
Fax Number: 5166560660

Provider Taxonomy:

Primary: 213ES0131X
Secondary (if any):
State: NY

Top Doctors in NY

 

About Dr. Matthew Scott Yasmer

Dr. Matthew Scott Yasmer (DR. MATTHEW SCOTT YASMER ) is Definition Podiatrist Physician in West Hempstead, NY. The NPI Number for Dr. Matthew Scott Yasmer is 1699713511.
The current location address for Dr. Matthew Scott Yasmer is 367 HEMPSTEAD AVE West Hempstead, NY 11552 and the contact number is 5164818099 and fax number is 5166560660. The mailing address for Dr. Matthew Scott Yasmer is 367 HEMPSTEAD AVE West Hempstead, NY 11552- 5164818099 (mailing address contact number - 5164818099).
Definition to come...

Provider Business Location on Map

FAQs:

What is the NPI Number for Dr. Matthew Scott Yasmer ?


Answer: The NPI Number for Dr. Matthew Scott Yasmer is 1699713511

Where is Dr. Matthew Scott Yasmer located?


Answer: Dr. Matthew Scott Yasmer is located at 367 HEMPSTEAD AVE West Hempstead, NY 11552.

What is the specialty for Dr. Matthew Scott Yasmer ?


Answer: The Specialty of Dr. Matthew Scott Yasmer is Definition Podiatrist Physician.

Are there any online reviews for Dr. Matthew Scott Yasmer ?


Answer: Yes! Check It Now.

Are there any other health care providers in West Hempstead, NY?


Answer: Yes, there are given below...

Medicare Physician & Other Practitioners

Information on services and procedures provided to Original Medicare (fee-for-service) Part B (Medical Insurance) beneficiaries by Dr. Matthew Scott Yasmer

Number of HCPCS 38
Number of Medicare Beneficiaries 826
Number of Services 2288
Total Submitted Charge Amount 190652.29
Total Medicare Allowed Amount 182506.19
Total Medicare Payment Amount 145141.24
Total Medicare Standardized Payment Amount 121384.62
Drug Suppress Indicator
Number of HCPCS Associated With Drug Services 0
Number of Medicare Beneficiaries With Drug Services 0
Number of Drug Services 0
Total Drug Submitted Charge Amount 0
Total Drug Medicare Allowed Amount 0
Total Drug Medicare Payment Amount 0
Total Drug Medicare Standardized Payment Amount 0
Medical Suppress Indicator
Number of HCPCS Associated With Medical Services 38
Number of Medicare Beneficiaries With Medical 826
Number of Medical Services 2288
Total Medical Submitted Charge Amount 190652.29
Total Medical Medicare Allowed Amount 182506.19
Total Medical Medicare Payment Amount 145141.24
Total Medical Medicare Standardized Payment Amount 121384.62
Average Age of Beneficiaries 82
Number of Beneficiaries Age Less 65 41
Number of Beneficiaries Age 65 to 74 139
Number of Beneficiaries Age 75 to 84 276
Number of Beneficiaries Age Greater 84 370
Number of Female Beneficiaries 546
Number of Male Beneficiaries 280
Number of Non-Hispanic White Beneficiaries 725
Number of Black or African American Beneficiaries 46
Number of Asian Pacific Islander Beneficiaries
Number of Hispanic Beneficiaries 33
Number of American Indian/Alaska Native Beneficiaries
Number of Beneficiaries With Race Not Elsewhere Classified
Number of Beneficiaries With Medicare & Medicaid Entitlement 250
Number of Beneficiaries With Medicare Only Entitlement 576
Percent (%) of Beneficiaries Identified With Atrial Fibrillation 0.21
Percent (%) of Beneficiaries Identified With Alzheimer's Disease or Dementia 0.63
Percent (%) of Beneficiaries Identified With Asthma 0.11
Percent (%) of Beneficiaries Identified With Cancer 0.15
Percent (%) of Beneficiaries Identified With Heart Failure 0.42
Percent (%) of Beneficiaries Identified With Chronic Kidney Disease 0.52
Percent (%) of Beneficiaries Identified With Chronic Obstructive Pulmonary Disease 0.21
Percent (%) of Beneficiaries Identified With Depression 0.61
Percent (%) of Beneficiaries Identified With Diabetes 0.41
Percent (%) of Beneficiaries Identified With Hyperlipidemia 0.7
Percent (%) of Beneficiaries Identified With Hypertension 0.75
Percent (%) of Beneficiaries Identified With Ischemic Heart Disease 0.63
Percent (%) of Beneficiaries Identified With Osteoporosis 0.13
Percent (%) of Beneficiaries Identified With Rheumatoid Arthritis / Osteoarthritis 0.62
Percent (%) of Beneficiaries Identified With Schizophrenia / Other Psychotic Disorders 0.1
Percent (%) of Beneficiaries Identified With Stroke 0.23
Average HCC Risk Score of Beneficiaries 2.1639

Medicare Part D Prescribers

Information on prescription drugs provided to Medicare beneficiaries enrolled in Part D (Prescription Drug Coverage), by physicians and other health care providers, aggregated by provider.

Provider Specialty Type Podiatry
Source of Provider Specialty
Number of Medicare Part D Claims, Including Refills 47
Number of Standardized 30-Day Fills 48.5
Aggregate Cost Paid for All Claims 962.21
Number of Day's Supply for All Claims 1115
Number of Medicare Beneficiaries 22
Number of Claims, Including Refills, for Beneficiaries Age 65+ 47
Including Refills, for Beneficiaries Age 65+ 48.5
Beneficiaries Age 65+ 962.21
Number of Day's Supply for All Claims for Beneficaries Age 65+ 1115
Number of Medicare Beneficiaries Age 65+ 22
Reason for Suppression of Brnd_Tot_Clms and Brnd_Tot_Drug_Cst
Total Claims of Brand-Name Drugs 0
Reason for Suppression of Gnrc_Tot_Clms and Gnrc_Tot_Drug_Cst
Total Claims of Generic Drugs, Including Refills 47
Aggregate Cost Paid for Generic Drugs 962.21
Reason for Suppression of Othr_Tot_Clms and Othr_Tot_Drug_Cst
Total Claims of Other Drugs, Including Refills 0
Aggregate Cost Paid for Other Drugs 0
Reason for Suppression of MAPD_Tot_Clmsand MAPD_Tot_Drug_Cst *
Number of Claims for Beneficiaries Covered by MAPD Plans
Aggregate Cost Paid for Claims Filled by Beneficiaries in MAPD Plans
Reason for Suppression of PDP_Tot_Clms and PDP_Tot_Drug_Cst #
Number of Claims for Beneficiaries Covered by Standalone PDP Plans
Aggregate Cost Paid for Claims Filled by
Reason for Suppression of LIS_Tot_Clms and LIS_Drug_Cst *
Number of Claims for Beneficiaries Covered by Low-Income Subsidy
Aggregate Cost Paid for Claims Covered by Low-Income Subsidy
Reason for Suppression of NonLIS_Tot_Clms and NonLIS_Drug_Cst #
Number of Claims for Beneficiaries Not Covered by Low-Income Subsidy
by Low-Income Subsidy
Total Claims of Opioid Drugs, Including 0
Aggregate Cost Paid for Opioid Drugs 0
Opioid Claims 0
Opioid_Tot_Clms divided by the Tot_Clms 0
Total Claims of Long-Acting Opioid Drugs 0
Aggregate Cost Paid for Long-Acting Opioid 0
Number of Day's Supply of All Long-Acting 0
Long-Acting Opioid Claims 0
Opioid_LA_Tot_Clms divided by the
Total Claims of Antibiotic Drugs, Including
Aggregate Cost Paid for Antibiotic Drugs
Antibiotic Claims
Reason for Suppression of Antpsyct_GE65_Tot_Clms and Antpsyct_GE65_Tot_Drug_Cst
Including Refills, for Beneficiaries Age 65+ 0
Aggregate Cost Paid for AntipsychoticDrugs for Beneficiaries Age 65+ 0
Reason for Suppression of Antpsyct_GE65_Tot_Benes
Number of Medicare Beneficiaries Age 65+Filling Antipsychotic Claims 0
Average Age of Beneficiaries 77.636363636
Number of Beneficiaries Age Less Than 65 0
Number of Beneficiaries Age 65 to 74
Number of Beneficiaries Age 75 to 84 11
Number of Female Beneficiaries
Number of Male Beneficiaries
Number of Non-Hispanic White 16
Number of Black or African American
Number of Asian Pacific Islander 0
Number of Hispanic Beneficiaries
Number of American Indian/Alaskan NativeBeneficiaries 0
Number of Beneficiaries with Race Not
Only Entitlement
Average Hierarchical Condition Category 1.025

More Providers in west-hempstead , ny

Dr. matthew Scott yasmer in Other Directories

Provider don't have other directory link yet.